Sector
PharmaceuticalsOpen
₹10.2Prev. Close
₹10.69Turnover(Lac.)
₹5.05Day's High
₹10.78Day's Low
₹10.1652 Week's High
₹16.5952 Week's Low
₹9.1Book Value
₹10.59Face Value
₹2Mkt Cap (₹ Cr.)
64.01P/E
0EPS
0Divi. Yield
019 Feb 2025
12:00 AM
EGM
20 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
8 Sep 2024
12:00 AM
AGM
Announcement Date: 08 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 14.24 | 13.67 | 7.36 | 7.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 26.22 | 23.04 | 28.09 | 25.49 |
Net Worth | 40.46 | 36.71 | 35.45 | 32.85 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1.26 | 22.75 | 31.07 | 28.91 |
yoy growth (%) | -94.43 | -26.75 | 7.45 | 19.58 |
Raw materials | -0.73 | -23.93 | -25.41 | -15.96 |
As % of sales | 57.65 | 105.17 | 81.78 | 55.2 |
Employee costs | -1.15 | -1.48 | -1.36 | -1.05 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -3.68 | -3.93 | 1.14 | 2.82 |
Depreciation | -0.72 | -1.34 | -1.36 | -1.33 |
Tax paid | 1.8 | 0.25 | -0.2 | -0.64 |
Working capital | -7.21 | -2.48 | -0.12 | 5.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -94.43 | -26.75 | 7.45 | 19.58 |
Op profit growth | -63.94 | -488 | -76.84 | 74.74 |
EBIT growth | -10.72 | -184.93 | -35.91 | 109.75 |
Net profit growth | -48.73 | -491.44 | -57.03 | 75.27 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
Dhananjaya Alli
Non-Exec & Non-Independent Dir
M H Rao
Non-Exec & Non-Independent Dir
Stanley Prabhakar Reddy
Non-Exec. & Independent Dir.
Umesh V Banakar
Non-Exec. & Independent Dir.
Chakravarthula Divya Bhavani
Non Executive Director
Umakanth Katta
Non Executive Director
Divakar Reddy Yerrabommanahalli
Managing Director
Murali Meraga
Whole Time Director
Pavan Sathvik Gilaka
Company Sec. & Compli. Officer
Barkha Jain
Non-Exec. & Independent Dir.
Naga Raja Madineni
Non-Exec. & Independent Dir.
Madhu Sudan Anchi
Non-Exec. & Independent Dir.
Swapna Priya Gunduboina
Non-Exec. & Independent Dir.
Anumala Ravi Chandra Kumar
Non-Exec. & Independent Dir.
Rama Mohan Manamasa
Plot No 10to14 16to20 APIIC,
Industrial Estate Chotyal,
Telangana -
Tel: 91-09291015956
Website: http://www.vistapharmaceuticals.com
Email: [email protected]
1-2-285,
Domalguda, J B Apartments,
Hyderabad - 500 029
Tel: 91-40-27642217 /2763
Website: www.aarthiconsultants.com
Email: [email protected]
Summary
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Compan...
Read More
Reports by Vista Pharmaceuticals Ltd
What is the Vista Pharmaceuticals Ltd share price today?
What is the Market Cap of Vista Pharmaceuticals Ltd?
What is the PE and PB ratio of Vista Pharmaceuticals Ltd?
What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?
What is the CAGR of Vista Pharmaceuticals Ltd?
What is the shareholding pattern of Vista Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.